| dc.creator | Carneiro Neto, José Abraão | |
| dc.creator | Bittencourt, Valéria Gusmão | |
| dc.creator | Oliveira, Cassius de | |
| dc.creator | Andrade, Rosana | |
| dc.creator | Carvalho Filho, Edgar Marcelino | |
| dc.date | 2018-02-26T17:22:22Z | |
| dc.date | 2018-02-26T17:22:22Z | |
| dc.date | 2014 | |
| dc.date.accessioned | 2023-09-26T20:11:06Z | |
| dc.date.available | 2023-09-26T20:11:06Z | |
| dc.identifier | CARNEIRO NETO, J. A. et al. The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy. Revista da Sociedade Brasileira de Medicina Tropical, v. 47, n. 4, p. 528-532, 2014. | |
| dc.identifier | 0037-8682 | |
| dc.identifier | https://www.arca.fiocruz.br/handle/icict/24944 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8850727 | |
| dc.description | CARVALHO FILHO, Edgar Marcelino de. “Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento”. | |
| dc.description | Brazilian National Research Council CNPq - (Conselho Nacional de Desenvolvimento Científico e Tecnológico | |
| dc.description | Urinary symptoms occur in 19% of human T-cell lymphotropic virus type 1 (HTLV-1)-infected patients who do not fulfi ll criteria
for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and in almost 100% of HAM/TSP patients. Few
studies have evaluated therapies for overactive bladder (OAB) caused by HTLV-1 infection. This case report describes the effect
of onabotulinum toxin A on the urinary manifestations of three patients with HAM/TSP and OAB symptoms. The patients were
intravesically administered 200 units of Botox®. Their incontinence episodes improved, and their OAB symptoms scores (OABSS)
reduced signifi cantly. These data indicate that Botox® should be a treatment option for OAB associated with HTLV-1 infection | |
| dc.format | application/pdf | |
| dc.language | eng | |
| dc.publisher | Sociedade Brasileira de Medicina Tropical | |
| dc.rights | open access | |
| dc.subject | HTLV-1 | |
| dc.subject | Bexiga hiperativa | |
| dc.subject | Botox | |
| dc.subject | HTLV-1 | |
| dc.subject | Overactive bladder | |
| dc.subject | Botox | |
| dc.title | The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy | |
| dc.type | Article | |
